Is RUBNF or MRK a better dividend investment in 2026?

RUBNF currently yields 4000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: RUBNF offers higher current income.

What is the dividend yield difference between RUBNF and MRK?

RUBNF has a forward dividend yield of 4000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 3997.24 percentage points.

Home › Compare › RUBNF vs MRK

RUBNF vs MRK: Dividend Comparison 2026

RUBNF yields 4000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RUBNF wins by $7175340620755.81M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RUBNF

● Live price

4000.00%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7175340620755.87M

Annual income

$6,839,006,593,197,835,000.00

Full RUBNF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — RUBNF vs MRK

📍 RUBNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RUBNF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RUBNF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RUBNF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RUBNF

Annual income on $10K today (after 15% tax)

$340,000.00/yr

After 10yr DRIP, annual income (after tax)

$5,813,155,604,218,160,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, RUBNF beats the other by $5,813,155,604,218,152,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RUBNF + MRK for your $10,000?

RUBNF: 50%MRK: 50%

100% MRK50/50100% RUBNF

Portfolio after 10yr

$3587670310377.96M

Annual income

$3,419,503,296,598,923,000.00/yr

Blended yield

95.31%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RUBNF

Analyst Ratings

Hold

Consensus: Hold

Altman Z

0.3

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RUBNF buys

MRK buys

No recent congressional trades found for RUBNF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRUBNFMRK

Forward yield	4000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$7175340620755.87M ✓	$56.8K
Annual income after 10y	$6,839,006,593,197,835,000.00 ✓	$9,798.13
Total dividends collected	$7152397773804.84M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: RUBNF vs MRK ($10,000, DRIP)

Year	RUBNF Portfolio	RUBNF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$410,700	$400,000.00	$11,206	$366.19	+$399.5K → RUBNF
2	$15,792,720	$15,353,271.03	$12,650	$502.35	+$15.78M → RUBNF
3	$568,657,142	$551,758,931.89	$14,407	$694.19	+$568.64M → RUBNF
4	$19,176,207,860	$18,567,744,718.20	$16,585	$967.82	+$19176.19M → RUBNF
5	$605,696,028,890	$585,177,486,479.73	$19,342	$1,363.89	+$605696.01M → RUBNF
6	$17,922,210,653,594	$17,274,115,902,681.27	$22,913	$1,947.19	+$17922210.63M → RUBNF
7	$496,869,793,504,300	$477,693,028,104,954.00	$27,662	$2,823.89	+$496869793.48M → RUBNF
8	$12,908,672,105,251,704	$12,377,021,426,202,104.00	$34,159	$4,173.35	+$12908672105.22M → RUBNF
9	$314,330,866,876,668,540	$300,518,587,724,049,200.00	$43,337	$6,308.80	+$314330866876.63M → RUBNF
10	$7,175,340,620,755,871,000	$6,839,006,593,197,835,000.00	$56,776	$9,798.13	+$7175340620755.81M → RUBNF

RUBNF vs MRK: Complete Analysis 2026

RUBNF — Stock

ArborGen Holdings Limited engages in the forestry genetics business. It provides its tree seedlings under the ArborGen brand name to forestry industry primarily in the United States and Brazil. The company was formerly known as Rubicon Limited and changed its name to ArborGen Holdings Limited in September 2019. ArborGen Holdings Limited was incorporated in 2001 and is based in Auckland, New Zealand.

Full RUBNF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this RUBNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RUBNF vs SCHD RUBNF vs JEPI RUBNF vs O RUBNF vs KO RUBNF vs MAIN RUBNF vs JNJ RUBNF vs ABBV RUBNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.